Mohammad Abdulelah

Mohammad Abdulelah


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2024 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
MAMohammad Abdulelah
Mohammad Abdulelah
MHMohammad Abu Hishmeh
Mohammad Abu Hishmeh
Infective pleural effusions are mainly represented by parapneumonic effusions and empyema. These conditions are a spectrum of pleural diseases that are commonly encountered and carry significant mortality and morbidity rates reaching upwards of 50%. The causative etiology is usually an underlying bacterial pneumonia with the subsequent seeding of the infectious culprit and inflammatory agents to the pleural space leading to an inflammatory response and fibrin deposition. Radiographical evaluation through a CT scan or ultrasound yields high specificity and sensitivity, with features such as septations or pleural thickening indicating worse outcomes. Although microbiological yields from pleural studies are around 56% only, fluid analysis assists in both diagnosis and prognosis by evaluating pH, glucose, and other biomarkers such as lactate dehydrogenase. Management centers around antibiotic therapy for 2–6 weeks and the drainage of the infected pleural space when the effusion is complicated through tube thoracostomies or surgical intervention. Intrapleural enzymatic therapy, used to increase drainage, significantly decreases treatment failure rates, length of hospital stay, and surgical referrals but carries a risk of pleural hemorrhage. This comprehensive review article aims to define and delineate the progression of parapneumonic effusions and empyema as well as discuss pathophysiology, diagnostic, and treatment modalities with aims of broadening the generalist’s understanding of such complex disease by reviewing the most recent and relevant high-quality evidence.

13 May 2025 in Medicine International
Verified
Journal Article
Open access
PDF file
MAMohammad Abdulelah
Mohammad Abdulelah
OHOmar Haider
Omar Haider
HAHussein Abdulelah
Hussein Abdulelah
KJKevin T. Jamouss
Kevin T. Jamouss
THThomas L. Higgins
Thomas L. Higgins
Venous access devices can be categorized based on the termination site of the tip of the catheter into central and peripheral access devices. Selecting the type of venous access device depends on various factors, including the condition of the patient, the anticipated duration of therapy, the use of vesicant or hyperosmolar therapies and the potential risk of complications. Peripheral intravenous catheters provide adequate venous access in the majority of hospitalized patients; however, their use is associated with high failure rates. Non‑tunneled central venous access catheters are typically used in critically ill patients and are ideally suited for short‑term use, while tunneled central catheters are utilized in those who require long‑term intravenous therapy due to their extended dwell times. Each of these devices has unique characteristics requiring an in‑depth understanding of the indications and current evidence‑based recommendations to optimize their use. The present narrative review aimed to describe the different types of venous access devices and recommendations for their use based on current evidence‑based recommendations. A narrative review of the literature was performed based on searches of the PubMed and Google Scholar database from 1990 through November 1, 2024. The type of device used, the insertion site, patient characteristics and clinical needs, and the risk of complications are factors that a provider needs to consider when ordering the placement of a venous access device are discussed. The present review also discusses the prevention of negative adverse events, such as bloodstream infections and thrombosis, associated with specific devices. In addition, current evidence‑based recommendations for device selection and indications for use are described. The present narrative review provides a detailed examination of venous access devices that are essential in the care and treatment of patients. Since venous access is associated with inherent risks, device selection and meticulous post‑insertion care are paramount in ensuring patient safety and successful therapy.

30 July 2024 in Current Problems in Cardiology
Verified
Journal Article
Closed access
MAMohammad Abdulelah
Mohammad Abdulelah
ZAZaid A. Abdulelah
Zaid A. Abdulelah
MAMuayad Azzam
Muayad Azzam
RGRuba Ghalayni
Ruba Ghalayni
HKHassan Kawtharany
Hassan Kawtharany
AAAhmed A. Abdulelah
Ahmed A. Abdulelah

1 January 2024 in Journal of Investigative Medicine High Impact Case Reports
Verified
Journal Article
Open access
MAMohammad Abdulelah
Mohammad Abdulelah
NKNicole Kasher
Nicole Kasher
GPGabriella Primera
Gabriella Primera
JMJessika Matta
Jessika Matta
RPRuchi Patel
Ruchi Patel
EDErnest DiNino
Ernest DiNino
Pulmonary nodules are commonly encountered in pulmonary practice. Etiologies could include infectious, inflammatory, and malignant. Placental transmogrification of the lung is an extremely rare etiology of pulmonary nodules. Such condition often presents as unilateral lesions in asymptomatic men. In general, such nodules are generally stable and grow extremely slowly. We highlight an unusual case of placental transmogrification of the lung (PLC) identified in a young female. The patient’s bilateral nodules were larger than what has been previously cited in the literature and exhibited growth over an 8-year follow-up period.

Verified
Journal Article
Open access
PDF file
MAMohammad Abdulelah
Mohammad Abdulelah
OHOmar Haider
Omar Haider
MMMatthew McAuliffe
Matthew McAuliffe
LALeen Al-Faris
Leen Al-Faris
JPJasmine Paadam
Jasmine Paadam
KJKirti Joshi
Kirti Joshi
Introduction: Hospital-acquired venous thromboembolisms (HA-VTEs) carry a significant health burden on patients and a financial burden on hospitals due to reimbursement penalties. VTE prophylaxis at our institute was performed through utilizing an order set based on healthcare professionals’ perceived level of risk. However, the use of standardized risk assessment models is recommended by multiple professional societies. Furthermore, integrating decision support tools (DST) based on the standardized risk assessment models has been shown to increase the administration of appropriate deep vein thrombosis (DVT) prophylaxis. Nonetheless, such scoring systems are not inherently flawless and their integration into EMR as a mandatory step can come at the risk of healthcare professional fatigue and burnout. We conducted a study to evaluate the incidence of HA-VTE and length of stay pre- and post implementation of a DST. Methods: We conducted a retrospective, pre–post-implementation observational study at a tertiary medical center after implementing a mandatory DST. The DST used Padua scores for medical patients and Caprini scores for surgical patients. Patients were identified through ICD-10 codes and outcomes were collected from electronic charts. Healthcare professionals were surveyed through an anonymous survey and stored securely. Statistical analysis was conducted by using R (version 3.4.3). Results: A total of 343 patients developed HA-VTE during the study period. Of these, 170 patients developed HA-VTE in the 9 months following the implementation of the DST, while 173 patients were identified in the 9 months preceding the implementation. There was no statistically significant difference in mean HA-VTE/1000 discharge/month pre- and post implementation (4.4 (SD 1.6) compared to 4.6 (SD 1.2), confidence interval [CI] −1.6 to 1.2, p = 0.8). The DST was used in 73% of all HA-VTE cases over the first 6 months of implementation. The hospital length of stay (LOS) was 14.2 (SD 1.9) days prior to implementation and 14.1 (SD 1.6) days afterwards. No statistically significant change in readmission rates was noted (8.8% (SD 2.6) prior to implementation and 15.53% (SD 9.6) afterwards, CI −14.27 to 0.74, p = 0.07). Of the 56 healthcare professionals who answered the survey, 84% (n = 47) reported to be dissatisfied or extremely dissatisfied with the DST, while 91% (n = 51) reported that it slowed them down. Conclusions: There were no apparent changes in the prevalence of HA-VTE, length of stay, or readmission rates when VTE prophylaxis was mandated through DST compared to a prior model which used order sets based on perceived risk. Further studies are needed to further evaluate the current risk assessment models and improve healthcare professionals’ satisfaction with DST.

25 July 2024 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
MAMohammad Abdulelah
Mohammad Abdulelah
RARamsha Abbas
Ramsha Abbas
SSSherin Samuel
Sherin Samuel
MAMohammad Abu-Hishmeh
Mohammad Abu-Hishmeh
Clinical judgment is essential in determining the need for specialist consultation. We evaluated patients for whom the pulmonary team was consulted for unspecified hypoxia or acute hypoxic respiratory failure to better understand the characteristics and outcomes of such encounters. We retrospectively studied patients who received consults for unspecified hypoxia or acute hypoxic respiratory failure at a tertiary center. Outcomes evaluated were length of stay, duration of follow-up, and clinical trajectory. We identified 103 patients over a 2-year period. The level of care was escalated in 69.9% (n = 72) of patients, and the majority had procedural interventions such as bronchoscopies and chest tube placement. Common diagnoses were pneumonia and volume overload. The mortality rate was 17.5% (n = 18). The mean length of stay was 24 days (standard deviation [SD] 24.1), with an average of 6.6 hospital days (SD 9.9) to consultation. The mean duration of consecutive follow-up was 4.5 days (SD 7.5). Patients who underwent procedures had a shorter duration of follow-up. Pulmonary consults were noted for common diagnoses with a high need for escalation in care and procedural interventions, highlighting the importance and appropriateness of specialist consultations. Further studies are needed to explore what triggers an unspecified consult.